D G Sherman

Summary

Affiliation: University of Texas Health Science Center
Country: USA

Publications

  1. ncbi request reprint Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial
    D G Sherman
    Division of Neurology, University of Texas Health Science Center, San Antonio 78284 7883, USA
    JAMA 283:2395-403. 2000
  2. ncbi request reprint Antithrombotic therapy in the acute phase: new approaches
    D G Sherman
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78299 3900, USA
    Cerebrovasc Dis 11:49-54. 2001
  3. ncbi request reprint The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison
    David G Sherman
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Lancet 369:1347-55. 2007
  4. ncbi request reprint Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?
    David G Sherman
    Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Cerebrovasc Dis 17:138-43. 2004
  5. ncbi request reprint Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control
    David G Sherman
    Division of Neurology Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    Stroke 38:615-7. 2007
  6. ncbi request reprint Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study
    David G Sherman
    University of Texas Health Science Center, San Antonio, USA
    Arch Intern Med 165:1185-91. 2005
  7. ncbi request reprint Lessons from the Stroke Prevention in Atrial Fibrillation trials
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, 7703 Floyd Curl Drive MC 7883, San Antonio, Texas 78229 3900, USA
    Ann Intern Med 138:831-8. 2003
  8. ncbi request reprint Ancrod
    David G Sherman
    Department of Medicine, University of Texas Health Science Center, San Antonio 78229 3900, USA
    Curr Med Res Opin 18:s48-52. 2002
  9. ncbi request reprint Reconsideration of TIA diagnostic criteria
    David G Sherman
    University of Texas at San Antonio Health Science Center, San Antonio, TX, USA
    Neurology 62:S20-1. 2004
  10. ncbi request reprint Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy
    Mina K Chung
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 46:1891-9. 2005

Detail Information

Publications13

  1. ncbi request reprint Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial
    D G Sherman
    Division of Neurology, University of Texas Health Science Center, San Antonio 78284 7883, USA
    JAMA 283:2395-403. 2000
    ....
  2. ncbi request reprint Antithrombotic therapy in the acute phase: new approaches
    D G Sherman
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78299 3900, USA
    Cerebrovasc Dis 11:49-54. 2001
    ....
  3. ncbi request reprint The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison
    David G Sherman
    Department of Medicine Neurology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Lancet 369:1347-55. 2007
    ..We aimed to compare the efficacy and safety of enoxaparin with that of unfractionated heparin for patients with stroke...
  4. ncbi request reprint Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?
    David G Sherman
    Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
    Cerebrovasc Dis 17:138-43. 2004
    ..Recent clinical trials have suggested that other antithrombotic agents may be beneficial in acute ischemic stroke. Two such agents are ancrod and abciximab. Abciximab is currently being investigated in a large randomized clinical trial...
  5. ncbi request reprint Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control
    David G Sherman
    Division of Neurology Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 3900, USA
    Stroke 38:615-7. 2007
    ..All patients with atrial fibrillation at increased risk for stroke should be continued on long-term anticoagulation even if they appear to have been successfully restored to sinus rhythm...
  6. ncbi request reprint Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study
    David G Sherman
    University of Texas Health Science Center, San Antonio, USA
    Arch Intern Med 165:1185-91. 2005
    ..The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study was a multicenter comparison of high-risk patients with AF who were randomized to either a sinus rhythm control or a rate control strategy...
  7. ncbi request reprint Lessons from the Stroke Prevention in Atrial Fibrillation trials
    Robert G Hart
    Department of Medicine Neurology, University of Texas Health Science Center, 7703 Floyd Curl Drive MC 7883, San Antonio, Texas 78229 3900, USA
    Ann Intern Med 138:831-8. 2003
    ..For patients at moderate risk for stroke, patient preferences and access to reliable anticoagulation monitoring are particularly relevant...
  8. ncbi request reprint Ancrod
    David G Sherman
    Department of Medicine, University of Texas Health Science Center, San Antonio 78229 3900, USA
    Curr Med Res Opin 18:s48-52. 2002
    ..The clinical studies of ancrod in patients with stroke have shown a benefit with ancrod treatment in neurological outcome with only a modest increase in bleeding risk...
  9. ncbi request reprint Reconsideration of TIA diagnostic criteria
    David G Sherman
    University of Texas at San Antonio Health Science Center, San Antonio, TX, USA
    Neurology 62:S20-1. 2004
  10. ncbi request reprint Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy
    Mina K Chung
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 46:1891-9. 2005
    ..The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) functional status substudy aimed to test the hypothesis that functional status is similar in rate-control and rhythm-control strategies...
  11. ncbi request reprint Safety and tolerability of arundic acid in acute ischemic stroke
    L Creed Pettigrew
    Stroke Program, Sanders Brown Center on Aging, and Department of Neurology, 101 Sanders Brown Building, University of Kentucky Medical Center, Lexington, KY 40536 0230, USA
    J Neurol Sci 251:50-6. 2006
    ..023 vs. placebo), 7 (p=0.002), 10 (p=0.003), and 40 (p=0.018). A dose of 8 mg/kg/h AA produced a favorable trend in reduction of NIHSS that should be confirmed in a future clinical trial...
  12. ncbi request reprint Transient ischemic attack--proposal for a new definition
    Gregory W Albers
    Stanford University School of Medicine Palo Alto, CA 94305, USA
    N Engl J Med 347:1713-6. 2002